Merger Squeeze-out Cash Compensation Determined at EUR 10.40
|
EQS-Ad-hoc: APONTIS PHARMA AG / Key word(s): Squeeze Out Publication of inside information pursuant to Article 17 of the Regulation (EU) No. 596/2014 Zentiva AG currently holds approximately 91.95% and, after deducting the number of treasury shares pursuant to section 62 para. 1 sentence 2 UmwG, approximately 93.83% of APONTIS PHARMA AG’s share capital and is therefore the major shareholder of APONTIS PHARMA AG as defined by section 62 para. 5 UmwG. Zentiva AG has determined the amount of the cash compensation to be EUR 10.40 per APONTIS PHARMA AG share. The court-appointed expert auditor has already indicated that, from a current standpoint, it will confirm the cash compensation to be adequate. The conclusion and notarization of the merger agreement between APONTIS PHARMA AG and Zentiva AG will take place today. At APONTIS PHARMA AG’s annual general meeting, which is expected to be held on 29 July 2025, a resolution will be adopted on transferring APONTIS PHARMA AG minority shareholders’ shares to Zentiva AG against a cash compensation of EUR 10.40 per share. The effectiveness of the merger squeeze-out is still subject to the approval by the APONTIS PHARMA AG annual general meeting and the registration of both the transfer resolution and the merger in the commercial register at the seat of APONTIS PHARMA AG, as well as the registration of the merger in the commercial register at the seat of Zentiva AG. Investor Relations CROSS ALLIANCE communication GmbH End of Inside Information
13-Jun-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | APONTIS PHARMA AG |
| Rolf-Schwarz-Schütte-Platz 1 | |
| 40789 Monheim am Rhein | |
| Germany | |
| E-mail: | ir@apontis-pharma.de |
| Internet: | https://apontis-pharma.de/ |
| ISIN: | DE000A3CMGM5 |
| WKN: | A3CMGM |
| Listed: | Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Scale), Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2154370 |
| End of Announcement | EQS News Service |
|
|
2154370 13-Jun-2025 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.